Contraindications for dns fluid
DNS fluid (Dextrose Normal Saline / 5% Dextrose in 0.9% NaCl) is contraindicated in hyperglycemia, hypernatremia, fluid overload states, and hypertonic conditions. It should be avoided in patients with heart failure, renal failure, and conditions where sodium or glucose loading is harmful.
Searching sources...
Reading File
Finding Sources
Searching the Web
DNS fluid 5% dextrose normal saline contraindications clinical
Here is a complete breakdown of contraindications for DNS (5% Dextrose in 0.9% Normal Saline) fluid:
Contraindications for DNS (D5NS) Fluid
DNS is a hypertonic crystalloid containing 5g dextrose + 0.9g NaCl per 100 mL, with an osmolarity of ~560 mOsm/L. Because it contains both glucose and sodium, contraindications arise from either component.
Absolute / Strong Contraindications
| Condition | Reason |
|---|---|
| Hyperglycemia / Uncontrolled Diabetes Mellitus | Glucose load worsens blood sugar; can precipitate hyperosmolar hyperglycemic state (HHS) |
| Hypernatremia | Additional sodium load worsens existing high serum sodium |
| Fluid overload / Hypervolemia | Hypertonic fluid draws water into vasculature and worsens volume excess |
| Congestive Heart Failure (CHF) | Sodium retention + volume loading stresses a failing heart; FDA label warns to use "with great care, if at all" |
| Severe Renal Insufficiency / Oliguric renal failure | Impaired sodium and water excretion leads to dangerous fluid retention and edema |
| Pulmonary Edema | Fluid loading aggravates lung congestion |
| Known hypersensitivity to dextrose (corn allergy) | Dextrose is derived from corn; can trigger allergic reactions |
Relative Contraindications / Strong Precautions
| Condition | Reason |
|---|---|
| Neurosurgical procedures / Raised intracranial pressure (ICP) | Dextrose is metabolized rapidly, leaving free water that can worsen cerebral edema; hypotonic shift post-metabolism |
| Hyponatremia | Should not be used to correct low sodium - the dextrose component renders it effectively hypotonic after metabolism |
| Edematous states (cirrhosis, nephrotic syndrome) | Sodium retention worsens fluid accumulation in third spaces |
| Patients on corticosteroids | Steroids promote sodium retention; additional sodium load is hazardous |
| Diabetic Ketoacidosis (DKA) | Glucose worsens ketosis and hyperglycemia (unless glucose is specifically needed after insulin correction) |
| Severe hepatic disease | Impaired glucose metabolism; risk of lactic acidosis from dextrose |
| Hypertonic states / Hyperosmolarity | DNS itself is hypertonic (~560 mOsm/L) and further increases osmotic load |
Administration Incompatibility
- Do NOT administer simultaneously with blood through the same IV set - dextrose causes pseudoagglutination and hemolysis of red blood cells. This is explicitly stated on the container label.
Key Points to Remember
- DNS is a hypertonic solution (560 mOsm/L vs. plasma ~285-295 mOsm/L), so it behaves differently from D5W (isotonic) or 0.45% saline (hypotonic)
- After the dextrose is metabolized, the remaining sodium load is equivalent to giving hypertonic saline, which is why it is dangerous in hypernatremia, heart failure, and renal failure
- In neurosurgical and head-injury patients, both 5% dextrose-containing fluids and hypotonic fluids are avoided - Ringer's lactate or normal saline is preferred
- The FDA prescribing information classifies no formal absolute contraindications for the combination product but lists CHF, severe renal insufficiency, and edematous states as conditions requiring extreme caution
Sources: FDA label for Dextrose 5%/0.9% NaCl; RxList drug monograph; DailyMed/NLM prescribing information
This is a shared conversation. Sign in to Orris to start your own chat.